Corticosteroids in the management of acute exacerbations

Dennis E. Niewoehner, Kathryn Rice

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Exacerbations of chronic obstructive pulmonary disease (COPD) have a major adverse impact on health status and place a serious burden on health care systems, particularly when they entail a visit to an emergency department or hospital admission (1). In 2000, COPD was responsible for 1.5 million emergency department visits and 726,000 hospitalizations in the United States (2). A hospital admission for COPD in the United States incurs average costs in excess of $16,000, so that hospitalization accounts for a large proportion of the total medical costs of caring for this disease (3,4). Because severe exacerbations are common, treatments that shorten their duration to even a small extent may provide substantial human and financial benefits in absolute terms.

Original languageEnglish (US)
Title of host publicationChronic Obstructive Pulmonary Disease Exacerbations
PublisherCRC Press
Pages241-250
Number of pages10
ISBN (Electronic)9781420070873
ISBN (Print)142007086X, 9781420070866
StatePublished - Jan 1 2008

Fingerprint Dive into the research topics of 'Corticosteroids in the management of acute exacerbations'. Together they form a unique fingerprint.

Cite this